Go to nanoparticles.org Home Page Particles 2006
Particles 2006 HomeParticles 2006 Home ProgramProgram Registration InfoRegistration Information Go to Registration FormRegistration Form
Go to Abstracts PageAbstract Submission Hotel InfoHotel Accomodations Go to ExhibitngExhibiting Workshop InfoWorkshops Go to DirectionsDirections
Photos from the Conference

Identify an Unidentified Conferee and Win a Lanyard!

Lost & Found

We thank the 480 participants for a great conference!

Particles 2006
Medical/Biochemical Diagnostic, Pharmaceutical, and Drug Delivery Applications of Particle Technology
13-16 May 2006
Wyndham Orlando Resort
Orlando, Florida
3D Model of an Immunoliposome
by Dr. R. Rezka, MDC, Berlin
and courtesy of Dr. Reto A. Schwendener

Co-Sponsored by

  • Particles Conference
  • The Division of Colloid and Surface Chemistry of the American Chemical Society
  • European Association of Pharma Biotechnology
  • American Association of Pharmaceutical Scientists

Plenary Speakers

    Francis Szoka, Jr. (University of California, San Francisco)
        Targetted Bioresponsive Nanolipid Particles
    Vincent Rotello (University of Massachusetts, Amherst)
        Nanoparticles: Scaffolds and Building Blocks
    Heinrich Hofmann (EPFL)
        Superparamagnetic Particles for Diagnostics and Therapeutics

International Organizing Committee

J. M. Asua (Spain)
V. Babak (Russia)
J. R. Baker (USA)
F. Boury (France)
D. Burgess (USA)
K. Caldwell (Sweden)
R. Duncan (UK)
M. El-Sayed (USA)
N. Garti (Israel)
K. Johnston (USA)
H. Kawaguchi (Japan)
J. H. Kim (Korea)
C. M. Lehr (Germany)
S. Margel (Israel)
H. Moehwald (Germany)
B. Moudgil (USA)
R. Mueller (Germany)
F. Nielloud (France)
T. Nilsen (USA)
R. Pfeffer (USA)
D. Poncelet (France)
M. C. Roco (USA)
P. Rogueda (UK)
J. L. Salager (Venezuela)
S. Simoes (Portugal)
P. T. Spicer (USA)
S. Svenson (USA)
J. Texter (USA), General Chair


Particles 2006 is an international conference examining the science, technology, and business aspects of medical/biochemical diagnostic, pharmaceutical, and drug delivery applications of particle technology. Symposia will address diverse topics including nanoparticles, hydrogels, chemical and drug delivery, controlled release, suspensions, inhalation, liposomes, micelles & microemulsions, characterization, gene delivery, chemical and biochemical diagnostics, separations, surface modification, critical and supercritical fluid applications, spray drying, emulsions, and multiple emulsions. The conference targets practicing scientists, clinical research physicians, engineers, managers, innovators, and entrepreneurs, and embraces the theme "particles for detection and treatment."

The conference format comprises 6 parallel tracks of approximately 280 invited and contributed oral papers. Approximately 100 contributed posters will be presented in the two poster sessions. Manuscripts of invited and contributed papers and posters are requested within 30 days of the end of the conference; these will be peer reviewed and published as the conference proceedings.

Conference Program

Invited Speakers   Speaker/Presenter Index

Saturday Evening, 13 May 2006
1800-1930 Opening Reception/Mixer/Exhibition

Sunday Morning, 14 May 2006

0800-0850
Session Chair: Diane Burgess, University of Connecticut
1. Plenary 1 - Francis Szoka, Jr. (University of California, San Francisco)
Targetted Bioresponsive Nanolipid Particles

0900-1230 Parallel Sessions
A1B1C1D1E1F1
A1 Nanoparticles & Hydrogels; B1 Emulsions; C1 Controlled Release; D1 Diagnostics;
E1 …Somes; F1 Particle Characterization

Sunday Afternoon, 14 May 2006
1400-1730 Parallel Sessions
A2G1H1D2I1J1
A2 Nanoparticles & Hydrogels; G1 Particle Toxicology; H1 Photodynamic & EM Therapy;
D2 Diagnostics; I1 Micelles, Dendrimers & Conjugates; J1 Gene Delivery

Sunday Evening, 14 May 2006
1800-1930 Poster Session P1/Reception/Exhibition

Monday Morning, 15 May 2006

0800-0850
Session Chair: Shlomo Margel, Bar Ilan University
95b. Plenary 2 - Vincent M. Rotello (University of Massachusetts, Amherst)
Nanoparticles: Scaffolds and Building Blocks

0900-1230 Parallel Sessions
A3K1L1D3E2M1
A3 Nanoparticles & Hydrogels; K1 Inhalation & Aerosols; L1 Cancer Targetting; D3
Diagnostics
; E2 …Somes; M1 Supercritical Fluid Processing

Monday Afternoon, 15 May 2006
1400-1730 Parallel Sessions
A4B2C2D4I2N1
A4 Nanoparticles & Hydrogels; B2 Emulsions; C2 Controlled Release; D4 Diagnostics;
I2 Micelles, Dendrimers & Conjugates; N1 Suspensions & Dispersions

Monday Evening, 15 May 2006
1800-1930 Poster Session P2/Reception/Exhibition

Tuesday Morning, 16 May 2006

0800-0850
Session Chair: Joe DeSimone, University of North Carolina
185. Plenary 3 - Heinrich Hofmann (EPFL)
Superparamagnetic Particles for Diagnostic and Therapeutic Applications

0900-1230 Parallel Sessions
A5G2O1D5E3J2
A5 Nanoparticles & Hydrogels; G2 Particle Toxicology; O1 Vaccine Delivery;
D5 Diagnostics; E3 ...Somes; J2 Gene Delivery

Tuesday Afternoon, 16 May 2006
1400-1730 Parallel Sessions
A6K2H2D6I3M2
A6 Nanoparticles & Hydrogels; K2 Inhalation & Aerosols; H2 Photodynamic & EM
Therapy
; D6 Diagnostics; I3 Micelles, Dendrimers & Conjugates; M2 Supercritical Fluid Processing

1730 Conference Ends


Session A1 (Sunday 0900-1210) Nanoparticles & Hydrogels
Session Chair: Hong Yang, University of Rochester

0900   2. Hans Bäumler; Carrier for nanoparticles - Targeted delivery of water insoluble drugs
0925
   3. Giulio Paciotti; Developing tumor targeted controlled release drug vectors on colloidal gold nanoparticles
0950
   4. Dan V.Goia; Preparation and characterization of electrostatically stabilized dispersions of gold nanoparticles for medical and biological applications
1005   Break
1025
   5. Arianna Friggeri; Low molecular weight hydrogelators as oral drug delivery systems
1040
   6. Kazunari Akiyoshi; Nanogel engineering for polymeric drug delivery
1105
   7. Michael Giersig; Cell growth and cell manipulation based on 2 and 3 dimensional organization of nanosized materials of different morphology
1130
   8. Julie Straub; Porous microparticle technology for imaging and drug delivery
1155
   9. Satoshi Seino; Development of magnetic nanocarrier consisting of gold and iron oxide for biomedical applications
1210   End of Session

Session A2 (Sunday, 1400-1730) Nanoparticles & Hydrogels
Session Chair: Hans Bäumler, Charité - Universitätsmedizin Berlin

1400
  50. S. Iwamoto; Novel methods of producing nano- and microsized particles composed of natural polyelectrolytes
1430
  51. Andreas Taubert; Peptide and polymer assembly-controlled nanoparticle formation
1455
  52. Kent Coulter; Development of nanoengineered platelets
1510   Break
1530
  53. Esko Kauppinen; Gas-phase synthesis and coating of multifunctional nano- and microparticles for drug delivery
1555
  54. Yuichi Yamasaki; DNA condensation mechanism revealed under fluorescence video-microscopy
1620
  55. Andrew Loxley; Novel nanoparticle technologies for cost-effective, targeted, non-systemic delivery of therapeutic agents
1635
  56. Tamoaki Hino; Silk microspheres prepared by spray-drying of an aqueous system
1700
  57. Igor Sokolov; Synthesis and applications of arrays of silica nanotubes
1715
  58. Carlos Gamazo; Use of flagellin and mannosamine nanoparticles as bioadhesive carriers for mucosal vaccination
1730   End of Session

Session A3 (Monday, 0900-1210) Nanoparticles & Hydrogels
Session Chair: Joseph Bringley, Eastman Kodak Company

0900
  96. Wolfgang Parak; Characterization and biological application of colloidal nanoparticles
0930
  97. Laurie Gower; Biomimetic processing methods for organic-inorganic particles
1000
  98. Xinqiao Jia; Hyaluronan-based hydrogel microspheres for vocal fold regeneration
1015   Break
1035
  99. Anna Musyanovych; Miniemulsions for biomedical applications
1050
101. Ron Boch; Ocular drug delivery using lipid, polymer and suspension formulations
1120
102. Sandy Rosenthal; Imaging cell surface receptors with ligand conjugated nanocrystals
1150
103. Zhengmao Li; Oral insulin delivery with biodegradable and biocompatible nanocapsules
1205   End of Session

Session A4 (Monday, 1400-1730) Nanoparticles & Hydrogels
Session Chair: Kui Yu, Steacie Institute for Molecular Sciences, Ottawa

1400
139. Paul Braun; Double direct templating of periodically nanostructured ZnS hollow microspheres
1430
140. Takashi Miyata; Signal biomolecule-responsive gels
1455
141. Jonghwi Lee; Preparation of polymer/drug nano- and micro-particles by electrospraying
1510   Break
1530
142. Bruno G. De Geest; Polyelectrolyte microcapsules for biomedical applications
1545
143. James Talton; Oral nanoparticle deivery
1610
144. Eugene Goldberg; Drug-loaded protein and DNA nano-meso-microspheres for non-systemic intratumorial chemotherapy
1635
145. Chang Chun Wang; Preparation of magnetic polymeric microspheres for application in biomedical fields
1700
146. Aravind Chakrapani; Fabrication of biodegradable polymer microdevices for controlled drug delivery systems
1715   End of Session

Session A5 (Tuesday, 0900-1230) Nanoparticles & Hydrogels
Session Chair: Robert Pelton, McMaster University

0900
186. Joe DeSimone; Keynote - Exploiting emerging techniques in imprint lithography to make highly uniform, shape-specific drugs, imaging agents and nano-carriers
0930
187. Jim Lee; Molecular spring assemblies of nanoparticles and nanowires
0955
188. Renato P. Camata; Development of nanoengineered calcium phosphate-based particulates for gene delivery
1010   Break
1030
189. Joseph F. Bringley; Precision assembly of multicomponent nanoparticulate colloids
1045
190. Yiguang Jin; The Self-assembly behavior of the cholesteryl derivatives of acyclovir and he preparation of self-assembled nanoparticles
1100
191. Neal K. Vail ; Targeted nanoparticles for bone therapies
1125
192. Shannon Morrison; Iron nanoparticles as magnetic carriers
1150
193. Stan Farnsworth; Broad-band efficacy determination for discrete silver nanoparticles
1205
194. Cory Berkland; Nanoclusters as a unique drug delivery platform
1230   End of Session

Session A6 (Tuesday, 1400-1730) Nanoparticles & Hydrogels
Session Chair: Shannon Morrison, Virginia Commonwealth University

1400
228. Robert Pelton ; Glucose sensing microgels
1425
229. Peter Burkhard; Peptide nanoparticles for medical applications: Novel drug targeting, delivery and vaccination strategies
1450
230. Qun (Treen) Huo; Preparation of monofunctional gold nanoparticle-dendrimer (pamam) conjugates by covalent approach
1505   Break
1525
231. Omid Veiseh; Chlorotoxin-bound superparamagnetic nanoparticles for brain tumor diagnosis and therapeutics
1550
232. L. Juillerat-Jeanneret; Functionalization of nanopaticles for disease detection and targeted drug delivery
1615
233. Hsien-Hsin Tung; Precipitation of an amorphous pharmaceutical solid
1630
234. Monique Smaïhi ; Semicarbazide functionalized silicate nanoparticles for peptide ligation
1645
235. Reynolds A. Frimpong; Integration of magnetic nanoparticles into temperature responsive hydrogel systems
1700
236. Brij Moudgil; Keynote - Engineered nanoparticulate systems for biomedical applications
1730   End of Session

Session B1 (Sunday, 0900-1200) Emulsions
Session Chair: Tommy Horozov, University of Hull

0900
10. Irwin Gruverman; Keynote - Optimizing drug delivery - Efficient formulation development and scaleable manufacturing methodology
0930
11. David Driscoll; Lipid injectable emulsions: Pharmacopeial and safety issues
0955
12. Maria-Teresa Celis; Droplet size distribution of liquid-liquid systems from UV-VIS spectra
1010   Break
1030
13. Lynn Gold; Applications of Vitamin E based formulations
1055
14. Takasi Nisisako; Generation of monodisperse double emulsions in a planar microfluidic network
1120
15. Robert Hoerr; Applying nanocomposite coatings on medical devices using electronanospray
1145
16. Csilla Kollar; Silicone based controlled release dressing for accelerated proteolytic debridement
1200   End of Session

Session B2 (Monday, 1400-1720) Emulsions - Particles from Emulsons
Session Chair: David Driscoll, Harvard University

1400
147. Ozgen Ozer; W/O/W multiple emulsions containing nitroimidazole derivatives for vaginal application
1425
148. Tommy Horozov; Mechanisms of emulsion stabilization by colloidal particles
1450
149. Katrin Ebert; Preparation of biodegradable nanoparticles by a membrane based process
1515   Break
1535
150. Hidekazu Yoshizawa; New functions of grafted-polymer layers of core/corona polymer nanospheres in bioseparation
1550
151. Dietmar Lerche; Rapid stability testing and shelf life determination of concentrated emulsions
1615
152. Christophe J. Barbé; Ceramispheres: Controlled release from sol-gel micro and nanoparticles
1630
153. Wei Lu; Double emulsion based synthesis of pegylated nanoparticles for brain delivery
1655
154. Yujie Dai ; Colloidal emulsion aphrons: Structure, principles, properties and applications
1720   End of Session

Session C1 (Sunday, 0900-1230) Controlled Release
Session Chair: Detlef Mueller-Schulte, MagnaMedics GmbH

0900
17. Heike Bunjes; Supercooled smectic nanoparticles – Development and characterization of a novel drug delivery systems
0925
18. Brian G. Amsden; Sustained and active protein delivery from photo-cross-linked biodegradable elastomer milli-cylinders
0950
19. Katarina Edsman; Pharmceutical application of catanionic complexes - sustained drug release from gels
1015   Break
1030
20. Ponisseril Somasundaran; Modified polyacrylic and polysaccharide nanoparticles for controlled extraction and release
1055
21. Dieter Trau; Enzymatic reactions in microcapsules
1110
22. Sabine Fischer; Bio goes Nano: The TNO Planomers® technology, developed to improve commonity plastics by using nanotechnology, opens new possibilities for biomedical materials like nanocomposites for tissue engineering or hybrid materials for drug delivery
1125
23. Irwin C.Jacobs; Development of formulations and equipment for spray drying of high value active ingredients for the pharmaceutical industry
1150
24. Kenneth K. S.Lau; All-dry encapsulation of fine pharmaceutics for controlled drug release
1205
25. Vince Rotello; Keynote - Drug, protein, and DNA delivery with glutathione-mediated release using gold nanoparticles
1230   End of Session

Session C2 (Monday, 1400-1730) Controlled Release
Session Chair: Heike Bunjes, Friedrich Schiller University, Jena

1400
155. Michael Pishko; Keynote - Encapsulation of drug nanoparticles in self-assembled macromolecular nanoshells
1440
159. Hideki Ichikawa; Acrylate-based  nanogels as microcapsular membrane components for peptide delivery
1510   Break
1530
158. Jacco Eversdijk; Functional microencapsulation using hybrid materials
1545
157. Sheng Qi; Investigation into the influence of fatty acid purity on the drug release behavior of taste-masking fatty acid microsphers
1600
160. Detlef Müller-Schulte; Thermosensitive magnetic nano- and microcarriers as contactless controllable drug carriers and tools
1630
161. Peter Markland; Microparticle formulation development - Considerations from bench top to clinical manufacturing
1700
162. Rick Rehrig; Vibrating nozzle processing in industrial microencapsulation
1715
163. Tinneke Van Thienen; On the synthesis and characterization of biodegradable dextran nanogels with tunable degradation properties
1730   End of Session

Session D1 (Sunday, 0900-1200) Diagnostics
Session Chair: Todd Krauss, University of Rochester

0900 26. Shlomo Margel; Keynote - Synthesis and characterization of nano and micron-sized particles of narrow size distribution for medical imagin applications
0930
27. Yuzhuo Li;
Dynamic NMR characterization of nanoparticles for medical imaging applications
0950
28. Terry Matsunaga; Perfluorocarbon nanobubbles as diagnostic and therapeutic agents
1010   Break
1030
29. Marc Herold; Molecularly imprinted nanoparticles for analytical and preparative separation of amino acid derivatives
1045
30. Reyad Sawafta; Nanomagnetic particles in rapid diagnostics
1105
31. John Forsayeth; Real time visualization of nano-liposomal delivery into primate brain by magnetic resonance imaging
1125
32. Jean-François Berret; Controlled clustering of superparamagnetic nanoparticles using block copolymers : Design of new contrast agents for magnetic resonance imaging
1140
33. Karin Caldwell; Multilayered nanoparticles: Characterization and bioanalytical use
1200   End of Session

Session D2 (Sunday, 1400-1715) Diagnostics
Session Chair: Yuzhou Li, Clarkson University

1400
73. Roger Leblanc; Keynote - Quantum dots as immunoassay probes
1430
74. Hedi Mattoussi; Development of FRET-based QD-bioconjugate sensors for detecting enzymatic activity
1455
75. Detlaf Müller-Schulte; Giant magnetic quantum dots as individually addressable high sensitive optical bar codes for diagnostics and bioanalytics
1510   Break
1530
76. Yongxian Wang; Synthesis of ultra-stable bare CdS nanocrystals with strong luminescence by hydrothermal synthesis
1545
77. Todd D. Krauss; Colloidal semiconductor quantum dots in selective labeling of pathogenic bacteria
1610
78. Robert M. Tsikhudo; A generic approach to biomolecular functionality on gold and silver nanoparticles
1635
79. David E. Cliffel; Epitope presentation on gold nanoparticles for immunoassay development
1700
80. Volker Mailänder; Surface modification of particles enhances intracellular uptake
1715   End of Session

Session D3 (Monday, 0900-1230) Diagnostics
Session Chair: Wolfgang Fritzsche, Institute for Physical High Technology, Jena

0900
118. Brigitte von Rechenberg; Keynote - Superparamagnetic iron oxide particles as a drug delivery system for in vivo application in the joint
0930
119. Taeghwan Hyeon; Generalized and large-scale synthesis of monodisperse nanocrystals of ferrites and oxides and their applications as MRI contrast agents and in drug delivery
0955
120. Paul S. Russo ; Silica-polypeptide composite particles
1010   Break
1030
121. Mohammad S. Uddin; Surface functionalized nano-magnetic particles for adsorprtion/desorption of biomolecules
1045
122. Marc Porter, Strategies for the design and readout of ultrahigh density immunodiagnostic platforms
1110
123. Andreas Hütten; Magnetic nanoparticles: Aapplications beyond data storage
1135
124. Shy Chyi Wuang; Functionalization of magnetic nanoparticles with biomolecules
1150
125. Dave Thomas; Particle population classification by micro-flow imaging
1205
126. Nguyen TK Thanh; Development of magnetic nanoparticles for biomedical application
1230   End of Session

Session D4 (Monday, 1400-1720) Diagnostics
Session Chair, Paul Russo, Louisiana State University

1400
164. Shawn P. Mulvaney; Fluidic force discrimination assays in complex media
1430
165. Geir Fonnum; Magnetic beads used in sample preparation for mass spectrometry
1500
166. Roel Wirix-Speetjens; Magneto-resistive immunosensors: Sensitivity enhancement by active guiding of superparamagnetic particles
1515   Break
1535
167. Wing Cheung Mak; Encapsulated microcrystalline particles as label systems for diagnostics
1550
168. Wolfgang Fritzsche; Chip-based molecular diagnostics using metal nanoparticles
1620
169. Dense F.S. Petri; Hybrid particles as substrates for biotargets and metallic ions
1635
170. Heinrich Haas; Assembly and in-vivo tracking of nanoparticulate carriers for neo-vascular targeting
1650
171. Swadeshmukul Santra; Tuning of luminescence intensity of manganese doped cadmium sulfide quantum dots by controlling surface passivation
1705
172. Matthias Frank; Single-particle bioaerosol mass spectrometry for medical and biochemical diagnostics and analysis
1720   End of Session

Session D5 (Tuesday, 0900-1230) Diagnostics
Session Chair: J. Manuel Perez, University of Central Florida

0900
206. Orlin D. Velev; Keynote - Colloidal assembly extended into the biomaterials domain: Composite coatings and membranes from live cells
0930
207. Yi Lu; Genetic control of nanoparticle assembly and its application in colorimetric sensing
0955
208. Robert I. MacCuspie; Development of a multiplex peptide nanotube-based pathogen assay
1010   Break
1030
209. Frank van Veggel; Surface modified lanthanide doped nanoparticles as new robust biolabels
1045
210. Tania Q. Vu ; Nanoparticle quantum dots for targeted neuromodulation
1100
211. Yvon Durant; Targeted and functional nanoparticles for biomedical diagnostics
1125
212. Femke De Theije; Detection of drugs of abuse using a magnetic biosensor
1150
213. K. Bonroy; Sensing substrates modified with gold nanoparticle films
1205
214. Beth Goins; Radiolabeled lipid nanoparticles for imaging and radionuclide therapy
1230   End of Session

Session D6 (Tuesday, 1400-1730) Diagnostics
Session Chair: Renato Camata, University of Alabama at Birmingham

1400
252. Manuel (Manny) Perez; Keynote - Magnetic biosensors in biodiagnostics
1430
253. Xiaohu Gao; Multifunctional quantum dots for molecular imaging and therapeutics
1455
254. Robert Nooney; Plasmon-enhanced fluorescence of dyes attached to polyelectrolyte coated metal nanoparticles
1510   Break
1530
255. Tao Liu; Nano-biosensor for detection of disease
1545
256. Hilde Jans; Biofunctionalization of water-dispersible gold nanoparticles
1600
257. Stephane Legastelois; A new particle-based immunoassay that depends on the quantitative detection of magnetic particles
1625
258. Jin Zhang; Cancer biomarker detection based on photoluminescence of semiconductor quantum dots and SERS of metal nanostructures
1650
259. Dave Thomas; Particle population classification by micro-flow imaging
1705
260. Kui Yu; Development of colloidal semiconductor nanocrystals as bio-imaging probes
1730   End of Session

Session E1 (Sunday, 0900-1230) …Somes
Session Chair: Laurence Navailles, Centre de Recherche Paul Pascal, Bordeaux
0900
34. David Thompson; Keynote - Comparative performance of transfection complexes derived from a family of bisvinyl ether cationic lipids
0940
35. Martin Caffrey; Lipidic cubic phases: Applications in membrane protein crystallogenesis and in uptake and delivery
1010   Break
1030
36. Alexander Couzis; Spatially addressable protein arrays based on proteoliposome self- assembly into microwells
1100
37. Terrence Scott; PROMAXX microsphere drug delivery technology
1130
38. Jan A.A.M. Kamps; Liposomes targeted to activated endothelial cells selectively affect glomerulonephritis in mice
1145
39. Shinichi Kaneda; TRM-484 steroid included in long circulating cationic lipsosomes actively tartgeting inflammatory tissues
1200
40. Dan Luo; DNA-based hydrogels, lipsosomes and nanobarcodes
1230   End of Session

Session E2 (Monday, 0900-1200) …Somes
Session Chair: Martin Caffrey, University of Limerick

0900
127. Gilbert Grant; Keynote - Liposomal bupivacaine: An ultra-long acting local anesthetic
0940
128. Indranil Nandi; Application of lipid based drug delivery system for water insoluble drugs
1010   Break
1030
129. Kenji Kono; Preparation of thermosensitive liposomes by use of amphiphilic block copolymers and their application to anticancer drug delivery
1100
130. Daryl Drummond; Use of novel intraliposomal stabilization strategies for forming highly stable and long circulating nanoliposome constructs for camptothecins and vinca alkaloids
1130
131. Laurence Navailles ; Dislocation loop mediated smectic melting
1200   End of Session

Session E3 (Tuesday, 0900-1200) …Somes
Session Chair: Ijeoma F. Uchegbu, University of Strathclyde

0900
215. David Needham; Keynote - A new paradigm for local drug delivery: Temperature triggered release liposomes for anti-tumor applications
0940
216. David Sheff; Retrograde delivery of bacterial toxins passes through the recycling endosome of mammalian cells
1010   Break
1030
217. Ramin Darvari; Polyelectrolyte self-assembly to modify surface properties of PROMAXX insulin microspheres
1045
218. Dian R. Arifin; Polymersome encapsulated hemoglobin (PEH): A novel type of oxygen carrier
1100
219. Krzysztof J. Dziewiszek; Liposomal delivery of all-trans-retinoic acid: Challenges and results
1130
220. Hiroyuki Nakamura; Transferrin-loaded nido-carborane liposomes: Synthesis and intracellular targeting to solid tumors for boron neutron capture therapy
1200   End of Session

Session F1 (Sunday 0900-1230) Particle Characterization
Session Chair: Frank Etzler, Boehringer-Ingelheim Pharmaceuticals

0900
41. P. Stephen Williams; Characterization of magnetic nanoparticles using quadrupole magnetic field-flow fractionation
0930
42. Hélène Dihang ; Colloidal stability of emulsions and nanoparticles in pharmaceutics
0955
43. Frank M. Etzler; Particle size analysis: Compartive results from several techniques
1010   Break
1030
44. A.P. Tinke; Particle size and shape characterization of nano- and submicron suspensions
1100
45. Natasha Starostina; AFM capabilities in characterization of particulate matter from Angstoms to microns
1115
46. Mike Bogan; Femtosecond pulse vacuum-ultraviolet-free electron laser diffraction scattering of polystyrene nanoparticles
1130
47. Chak K. Chan; Understanding the efflorescence of supersaturated droplets using fluorescence spectroscopy
1200
48. Tim B. Van der Wood, Three dimensional characterization of pharmaceutical powders by scanning white light interference microscopy
1215
49. Dietmar Lerche; Potential of microcapsules made from plant pollen for application in chromatography
1230   End of Session

Session G1 (Sunday, 1400-1700) Particle Toxicology
Session Chair: Roberta Brayner, Université Paris 7-Denis Diderot

1400
59. Vicki Colvin; Structure-function relationships of nanoparticles and their toxicity - A general introduction to nanomaterials and their uses in medicine
1440
60. Hong Yang; Nanoparticle-induced biological responses: Effect of size, shape and surface chemistry
1510   Break
1530
61. Daniel J. Watts; Phytotoxicity of some manufactured nanoparticles
1600
62. Janos Szebeni; Complement-mediated hypersensitivity reactions to nanoparticulate drugs and solvents systems
1630
63. Natalia Varaksa; Aqueous dispersions of carbon nanotubes for biological testing and applications
1645
64. Roberta Brayner; Toxicological impact studies based on Escherichia coli bacteria in an ultrafine ZnO nanoparticles colloidal medium
1700   End of Session

Session G2 (Tuesday, 0900-1200) Particle Toxicology
Session Chair: Janos Szebeni, Semmelweis University, Hungarian Academy of Sciences

0900
195. Vicki Stone; Keynote - The cellular and molecular toxicity of low solubility nanoparticles
0940
196. Robert DeLong; Formulation processes and characterization of DNA and siRNA nanoparticles
1010   Break
1030
197. Tridib K. Bhowmick; Physicochemical analysis and effects on yeast cells of a particulate traditional Indian medicine, jasada bhasma
1045
198. Gan-Moog Chow; Physical properties and cytotoxicity of inorganic nanoparticles for biomedical applications
1110
199. Robert Hurt; Green nanotechnology through collaborative research on mechanisms of nanomaterial toxicity
1135
200. James L. McGrath; Nanoparticle interactions with the cytoskeleton
1200   End of Session

Session H1 (Sunday, 1400-1720) Photodynamic Therapy
Session Chair: Ross W. Boyle, University of Hull

1400 70. Robert Ivkov; Development of tumor targeting magnetic nanoparticles for cancer therapy
1430 66. Wei Chen; Nanoparticle self-lighting photodynamic therapy for cancer treatment
1500 67. Min Hu; Time-resolved spectroscopy study of the photothermal properties of gold nanocages
1515   Break
1535 68. Gereon Huettmann; Laser irradiated gold nanoparticles: A new tool for selective mainpulation of cells and biomolecules
1605 69. Naoto Oku; Angiogenic vessel-targeted cancer therapy
1635 71. Cornelus F. van Nostrum; Methacrylamide-oligolactates as building blocks for targeted biodegradable polymeric micelles to deliver photosensitizers
1650 72. Leanne B. Josefsen; Porphyrin-nanoparticle sensors for detecting cellular response(s) to oxidative stress
1720   End of Session

Session H2 (Tuesday, 1400-1705) Photodynamic Therapy
Session Chairs: Alfred Fahr, University of Jena

1400 245. Alfred Fahr; Liposomal formulations of a photosensizer: Green light for an old substance
1430 246. Gemunu Happawana; Use of a scattering element and direct deionized water cooling in high power semiconductor diode lasers to enhance the beam divergence and performance for use in photodynamic therapy (PDT)
1500 247. Dongling Ma; Developing multifunctional nano-architectures: Luminescent and superparamagnetic
1515   Break
1535 248. Gloria J. Kim; Cancer nanotechnology: Designing multifunctinal nanostructures for targetting tumor cells and vasculatures
1605 249. Sebastien Vasseur; La0.75Sr0.25MnO3-based magnetic nanoparticles as potential heat mediators in oncology
1620 250. Ross W. Boyle; Photosensitiser-macromolecule conjugates for targeted photodynamic therapy
1650 251. Jun Shao; Indocyanine green-loaded nanoparticulate delivery systems for superficial tumor diagnosis and treatment
1705   End of Session

Session I1 (Sunday, 1400-1730) Micelles, Dendrimers & Conjugates
Session Chair: Michael Giersig, CAESAR Research Center, Bonn

1400 81. Vladimir Torchilin; Keynote - Polymeric micelles: Potential as pharmaceutical nanocarriers
1440 82. Rex P. Hjelm; Self-assembly of surfactant aided delivery systems
1505   Break
1525 83. Afsaneh Lavasanifar; Polymeric micelles for tumor targeted delivery of P-glycoprotein inhibitors
1550 84. Christine Allen; Engineering copolymer materials and micelles for targeted delivery of hydrophobic drugs
1615 85. Francois Ravenelle; Nanodelivery using block copolymers: A Propofol solution
1640 86. Kent Jørgensen; Tumor triggered activation and release of drugs from lipid based drug and prodrug nanocarriers
1705 86b. Natalya Rapoport; Drug-loaded nanoemulsions/microbubbles for combined tumor imaging and treatment
1730   End of Session

Session I2 (Monday, 1400-1730) Micelles, Dendrimers & Conjugates
Session Chair: Sonke Svenson, Dendritic Nanotechnologies

1400 173. A.T. (Sandy) Florence; Keynote - Dendrimers, dendrons, dendrisomes and dendriplexes as carriers in drug and gene delivery
1440 174. Sonke Svenson; Dendrimers: A platform for custom-designed drug delivery
1510   Break
1530 175. Thor Nilsen; What constitutes a particle? Assembly of 30-500 nm dendritic (fractal) hyperpolymers via sequence recognition enabled polymers
1600 176. Victor Lin; Functionalized mesoporous silica nanoparticles for gene transfer, intracellular controlled release, and biosensor applications
1630 177. Joseph Backer; A standardized procedure for derivatization of nanoparticles with functionally active proteins
1700 178. Tao L. Lowe; Branched nanoparticles for drug delivery across the blood brain barrier
1730   End of Session

Session I3 (Tuesday, 1400-1730) Micelles, Dendrimers & Conjugates
Session Chair: Tao L. Lowe, Penn State University

1400 261. Ijeoma F. Uchegbu; Keynote - Nanomedicines for efficient drug and gene delivery
1440 262. Bill Turnell; Novel polymer technology for the delivery of biological macromolecules
1510   Break
1530 263. Robert W. Lee; Micellar nanoparticles
1600 264. Martin Woodle; Tissue targeted nanoparticles for systemic delivery of nucleic acid agents enables siRNA therapeutics
1630 265. Chun Li; Poly-L-glutamic acid as a building block for nanomedicine: From theapeutics to multimodality diagnostics
1700 266. Meike Harms; Formation of reverse micellar type versus surface modified solid lipid nanoparticles
1730   End of Session

Session J1 (Sunday, 1400-1730) Gene Delivery
Session Chair: David Thompson, Purdue University

1400 87. Mizuo Maeda; Non-crosslinking aggregation of DNA-carrying nanoparticles for gene diagnosis
1430 88. Jon Preece; Gluatathione degradable and pH modulatable polycation/DNA nanoplexes for gene delivery
1455 89. Rumiana Koynova; Lipid phase control of DNA delivery
1510   Break
1530 90. Diane Burgess; Gene delivery and quantum dot assisted intracellular trafficking
1600 91. Wee Beng Tan; Multifunctional nanoparticles for imaging assisted gene therapy
1630 92. Roberta Carbone; Cluster assembled nanostructured TiO2 film mediates efficient and safe retroviral gene transduction in primary adult human melanocytes for ex-vivo gene therapy
1645 93. Harald Petry; JC virus-like particles: Size dependent in vitro DNA packaging and gene delivery
1700 94. Pauline Li ; Amphiphilic core-shell nanoparticles with poly(ethyleneimine) shells as potential gene delivery carriers
1730   End of Session

Session J2 (Tuesday, 0900-1230) Gene Delivery
Session Chair: Jon Preece, University of Birmingham

0900 221. Larry Brown; Keynote - Nucleic acid microspheres for Type 1 diabetes intervention
0940 222. Sean Sullivan; Development of nanotransfection complexes for systemic treatment of cancer
1010   Break
1030 223. Sarah W. Kamau; Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field
1045 224. David Thompson; Synthesis, characterization & triggered dethreading of cyclodextrin-polyethylene glycol polyrotaxanes bearing ceavable “click” endcaps
1115 225. Sang-Kyung Lee; Targeted neuronal delivery of a single antiviral siRNA protects mice against encephalitis caused by two distinct flaviviruses
1130 226. Chong-Su Cho; Receptor-mediated gene delivery using chitosan derivatives in vitro and in vivo
1200 227. Lou Zumstein; Nanoparticle mediated delivery of tumor suppressor genes
1230   End of Session

Session K1 (Monday, 0900-1230) Inhalation & Aerosols
Session Chair: Hans Leuenberger, Institute of Pharmaceutical Technology, Basel

0900 104. Philippe Rogueda; Keynote - The nanoscale in inhalation delivery
0940 105. Uday Kompella; Particulate systems for pulmonary drug delivery: Safety, sustained release, and efficacy
1010   Break
1030 107. Mark Bumiller; A study of liquid properties and droplet size distributions of some common nasal decongestant spray formulations
1045 109. Jim Blanchard; Advances inliquid aerosol delivery systems
1115 106. Amy M. Waligorski; An ingredient-specific method for particle size characterization of corticosteroid nasal sprays
1130 110. Robert Cook; Embracing particle engineering for inhalation drug products
1200 111. Jimmy Yun; Design and production of ultrafine active pharmaceutical ingredients under high gravity environment
1230   End of Session

Session K2 (Tuesday, 1400-1725) Inhalation & Aerosols
Session Chair: Andrew Parker, Molecular Profiles, Ltd.

1400 237. David L. Gardner; Keynote - Factors to consider in developing a dry powder inhaler
1430 238. Andrew Martin; Particle fabrication for aerosol drug delivery
1455 239. Philippe Rogueda; Particle aggregation in therapeutic aerosols
1510   Break
1530 240. Michael Lipp; An overview of Alkermes AIR® dry powder particle formulation technology for pulmonary delivery
1555 241. Matti Murtomaa; Electrostatic measurement methods in pharmaceutical aerosols
1620 242. Niklas Sandler; Powder surface image analysis in screening of functional bulk properties of pharmaceutical particles
1645 243. Jimmy Yun; Novel porous hollow silica nanoparticles for drug/pesticide release control
1700 244. Hans Leuenberger; FDA’S pharmaceutical CGMPS for the 21st century; Do we need a special research initiative in pharmaceutical powder particle technology to comply with the new requirements?
1725   End of Session

Session L1 (Monday, 0900-1200) Cancer Targetting
Session Chair: Afsaneh Lavasanifar, University of Alberta

0900 112. X.Y. (Shirley) Wu; Keynote - New polymer-lipid hybrid nanoparticles for enhanced anticancer drug delivery
0940 113. Kathleen F. Pirollo; A versatile tumor targeting nanoadelivery platform for cancer diagnosis and therapy
1010   Break
1030 114. Iris V. Enriquez; DNA mesospheres as drug delivery vehicles for localized cancer chemotherapy
1045 115. P. Low; Ligand-mediated targeting of nanoparticles and low molecular weight drugs to cancer cells and inflammatory immune cells
1110 116. Balaji Panchapakesan; Single wall carbon nanotube nanobomb agents for cancer therapeutics
1135 117. Bob (RJ) Lee, Folate rceptor-targeted liposomes and nanoparticles for caner therapy
1200   End of Session

Session M1 (Monday, 0900-1230) SCF Processing
Session Chair: Paolo Caliceti, Universty of Padua

0900 132. Keith Johnston; Particle engineering and formulation for enhanced bioavailability of poorly water soluble drugs
0935 133. Steve Howdle; Particles for drug delivery and medical applications: A supercritical approach
1000 134. Jennifer A. Green; Investigation into particle size variations with process parameters using Nektar supercritical fluid technology
1015   Break
1035 135. Boris Shekunov; New particle technologies for drug delivery
1105 136. Ram B. Gupta; Formation of drug nanoparticles and microparticles using supercritical CO2
1135 137. Bob Sievers; Drug delivery applications of particle technology using CAN-BD processing
1205 138. Sung-Joo Hwang; Nanoparticles for enhanced solubility and bioavailability of poorly-water soluble drugs using supercritical fluid technology
1230   End of Session

Session M2 (Tuesday, 1400-1730) SCF Processing
Session Chair: Ram B. Gupta, Auburn University

1400 267. Neil Foster; Keynote - Utilization of dense gas technologies for the fabrication and formulation of nano-biomaterials
1435 268. Matt Yates; Microencapsulation through hybrid aqueous/supercritical carbon dioxide processing of polymer colloids
1500 269. Ana Rita C. Duarte; Exploring supercritical fluid technology for the development of controlled drug delivery
1515   Break
1535 270. Katsuto Otake; Liposome formation with supercritical CO2 as an alternative solvent
1600 271. Gerhard Muhrer; Solid dispersions by compressed fluid antisolvent precipitation
1630 272. Verreck, Geert; The use of compressed carbon dioxide to broaden the applicability of hot stage extrusion for drug delivery
1700 273. Paolo Caliceti, Fabrication of lipid nanoparticles for low molecular weight and biotech drug delivery by gas compressed techniques
1730   End of Session

Session N1 (Monday, 1400-1700) Suspensions and Dispersions
Session Chair: Mark Bumiller, Malvern Instruments

1400 179. Rainer H. Müller; Keynote - Nanosuspensions for the delivery of poorly soluble drugs - State of art and latest developments
1440 180. Ingrid Fischbach; Nanosuspensions of poorly soluble active ingredients
1510   Break
1530 181. Ingo Leubner; Size control of nanoparticles in continuous crystallizations
1545 182. Hemant Joshi ; Applications of nanotechnology in the pharma industry – An overview
1615 183. Christian Johansson; Electrostatic interacations between lysozyme and poly(acrylic acid) microgel particles
1630 184. Maria-Teresa Celis; Use of particles as emulsion and foam stabilizers
1700   End of Session

Session O1 (Tuesday, 0900-1200) Vaccine Delivery
Session Chair: Bill Turnell, Medivas

0900 201. Gary Fujii; Keynote - Nanoparticle based vaccine design: The VesiVax system
0940 202. Thomas Luby; Clinical development of a therapeutic microparticle formulation
1010   Break
1030 203. Ana M. Carmona-Ribeiro; Biomimetic particles for vaccine design
1045 204. Thierry Delair; Design of synthetic colloidal antigen carriers for vaccine purposes
1115 205. Balaji Narasimhan; Novel injectable biomaterials for protein and vaccine delivery
1145 205b. Sarah Hook; Nanoparticulate vaccine formulations
1200   End of Session


Poster Session P1 (Sunday, 1800-1930)
Session Chair: John Texter, Eastern Michigan University

General Papers

274. Venisetty R. Kumar; Pharmacokinetics and antileishmanial activity of mannose grafted amphotericin B lipid nanospheres
275. Venisetty R. Kumar; Formulation and quality control of gastroretentive tablets of ranitidine hydrochloride
276. Kevin A. Heitfeld; Smart membranes for flavor delivery
277. Ganesan Alasundaram; Increased osteoblast functions on Ti nanopatterned with peptides
278. Daniel J. Burnett; Correlation of polymer energetics and drug release rates 279. Daniel J. Burnett; Investigating the kinetics of moisture-induced crystallization of amorphous lactose
279b. Ying Gao; The utility of releasable PEG as a drug delivery platform for siRNA

Nanoparticles & Hydrogels

280. Ginger Denison Rothrock; Scalable fabrication of monodisperse, shape-specific organic nanoparticles for use as delivery vectors
281. Virginia Saez-Martinez; Chemical functionalization of poly(nitrophenyl acrylate-co-methacrylamide) microgels with pH-sensitive groups and a targeting ligand
282. Chul Ho Park; Nanoparticle preparation of ?–lipoic acid susceptible to polymerization
283. Boon Sing Ng; Synthesis, functionalization and transport properties of mesostructured particles
284. Withdrawn
285. Michihiro Nakamura ; Synthesis and characterization of silica nanoparticles with high fluorescence
286. Nobuyuki Morimoto; Enzymatic synthesis and characterization of nanogels by self-assembly of hydrophobized poly(L-lysine)-amylose conjugates
287. Yoshitake Masuda; Invited Poster - I. Control of crystallization for medical applications: I - Control of nucleation and growth of magnetite particles for cancer heat immunotherapy; II - Spherical particle-assembly by two-solution method for drug delivery system
288. Eun-Jung Kim; Solid lipid nanoparticles to overcome multi-drug resistence in cancer
289. Liisa T. Kuhn; Effect of nano-sizing calcium phosphate/cisplatin coordination complexes on in vitro drug release
290. Jianhua Hu; Biodegradable polymer aggregates prepared by amphiphilic poly(hydroxyethyl aspartamide-co-propyl aspartamide) grafted with (lactide) for drug deliverly
290b. Jarno Salonen; Enhanced solubility of poorly soluble drugs using mesoporous silicon microparticles as drug deliverying vehicles
290c. Jean Marie Devoisselle; Characterization and release properties of hybrid lipid/silica nanoparticles
290d. Mari Fujimoto; Characterization of GLU-containing elastic polypeptide nanoparticles by ?-irradiation for application to DDS

Diagnostics

291. Sudip Nath; Synthesis, characterization and localized surface plasmon resonance study of silver organosol
292. Wee Beng Tan; Water-soluble fluorescent LaF3:Ln3+ nanocrystals for bio-applications
293. Igor Sokolov; Fluorescent silica beads for detection of cervical cancer
294. Jaswinder Sharma; DNA-templated self-assembly of two dimensional and periodical gold nanoparticle arrays
295. Anna Galperin; Synthesis and characterization of polymeric microspheres of narrow size distribution containing iodine for x-ray imaging applications
296. E. Sócrates. T. Egito; Incorporation of magnetic particles in polymer systems of xylan
297. E. Sócrates. T. Egito; Magnetite particle dissolution at gastric pH
298. Detlaf Müller-Schulte; Composite thermoresponsive microgel core decorated with magnetic nanoparticles
299. Detlaf Müller-Schulte; Magnetic nanoparticles – Polyelectrolyte interaction: A layered approach for biomedical application
300. Arnold J. Kell; Functionalized superparamaganetic nanoparticles as pathogen capture probes
301. Marc Herold; Core-shell nanoparticles with covalently linked TNF for cell signalling investigations
302. Marc Herold; Novel nanoparticles with activated ester surface prepared by emulsion polymerization of polymerizable surfactants
Inhalation
303. Janne Raula ; Production of novel multicomponent pharmaceutical nano and microparticles with an aerosol flow reactor method
304. Philippe Rogueda; Size and concentration monitoring of HFA suspensions
305. David P. Brown; Dispersion of novel inhalation drug powders with nanocrystalline L-leucine coating
305b. Sebastien Vasseur; Design of folate-targeted iron oxide nanoparticles and in vitro uptake in a folate-resptor expressing tumor model
305c. Qiangbin Wang; Superparamagnetic,highly photoluminescent Fe3O4/CdSe@ZnS quntum dot/SiO2 composite micropsheres

Characterization

306. Andrew Parker; Quantitative hardness and surface characterization by atomic force microscopy for use in early stage screening of pharmaceutical formulations
307. Ben Lich; Particle size distribution characterization of sub-micron suspensions using electron microscopy
308. Dietmar Lerche ; Methods for characterization of micro- and nano-sized particles and capsules
309. Sarah Hook; Characterizing bicontinuous cubic nanoparticles by cryo field emission scanning electron microscopy
310. Wolfgang Fritzsche; Characterization of metal deposition on nanoparticles at single particle level
311. Lizandra Castro; Adhesion forces between hybrid colloidal particles and concanavalin A
312. Amber Clausi; Investigation of the particle size distribution and zeta potential of aluminum hydroxide adjuvant following freeze drying and freeze thawing

Super Critical Fluid Processing

313. A.R. Sampaio de Sousa; Incorporation of hydrophilic compounds in solid lipid particles using supercritical fluid technology
314. Ana Rita C. Duarte; Acetazolamide controlled release from microparticles prepared by SAS

Particle Toxicology

315. Giovana R. Tofoli; Pharmacological and histological evaluation of hydroxypropyl—cyclodextrin-bupivacaine inclusion complex
316. Tammy Oreskovic; In vitro testing of vascular smooth muscle cells exposed to unmodified multiwalled carbon nanotubes
317. Regine Hedderich; NanoCare - Chances and risks of manomaterials



Poster Session P2 (Monday, 1800-1930)
Session Chair: John Texter, Eastern Michigan University

General Papers

320. Shy Chyi Wuang; Surface functionalization of magnetic nanoparticles via surface-initiated atom-transfer radical polymerization (ATRP)
321. Krassimir P. Velikov; Colloidal delivery systems for functional foods
322. Alex I. Smirnov; Template-assisted self-assembly of polymerizable lipid nanotubes
323. Eik Leupold; The uptake mechanism of an APOE-derived peptide depends on its aggregational state
324. Daniel J. Burnett; Quantifying low levels of amorphous content using vapor sorption techniques
325. Daniel J. Burnett; Investigating the effects of protein concentration on the glass transition behavior of lyophilized protein-sugar formulations

Nanoparticles & Hydrogels

326. Meike Harms; Surface modified solid liIpid nanoparticles
327. Jessica Hain; Hybrid microgel particles with zinc sulfide inclusions
328. Larken E. Euliss; Exploiting emerging techniques in imprint lithobraphy to make highly uniform, shape-specific drugs, imaging agents, and nano-carriers
329. Nelly Fransén; Development and characterization of interactive mixtures with a fine particulate, mucoadhesive carrier for nasal drug delivery
330. Bruno G. De Geest; Monodisperse microgel synthesis inside microfluidic devices
331. Jerald W. Darlington; Modified nano-bentinite anit-viral activity against the herpes simples virus type 1, rhinovirus type 37, and rotovirus
332. José F. Almeida; Novel crosslinked chitosan and dextran gels as drug delivery systems
333. Christina A. Bauer; Silica nanoparticle formation in confined environments via biomimetic catalysis
334. Jean-Francois Berret; Nanoparticle-polymer complexation electrostatic self-assembly as a route to stable dispersions of hybrid nanocolloids
335. Etienne Duguet; One-step synthesis of spinel iron oxide-based core-corona nanoparticles for in vivo applications
335b. Yosuke Okamura; Prolongation effects of hemostatic efficacy of poly(ethylene glycol)-modified polymerized albumin particles carrying fibrinogen-?-chain dodecapeptide
335c. Yosuke Okamura; Preparation of albumin nano-sheets using patterning hydrophobic monolayers

Photodynamic & EM Therapy

336. Ji-Hun Yu; Fabrication and characterization of SiO2 and MgO coated Fe2O3 nanoparticles for hyperthermia applications
337. Sang-Eun Park; Preparation of gold nanocomposites with dielectric magnetic cores for targeted photothermal therapy

Diagnostics

338. Withdrawn
338b. Ronald A. Wassel; Dispersion of superparamagnetic iron oxide nanoparticles in poly(D,L-lactide-co-glycolide) nanoparticles
339. Sofia Martins; Detection of hybridization reactions on microparticles by template dependent extension
340.Roberta Brayner; Formation of hybrid nanoparticle-alginate microcapsules for bio-detection applications
341. Angelika Müller; Magnetic nanoparticle-loaded erythrocytes as magnetic resonance imaging contrast agents
342. Beata Chertok; Magnetic nanoparticles for possible simultaneous MR imaging and drug therapy of brain tumors
343. Katarzyna Derwinska; Hydrogels and nanoparticles in microarrays for food control
344. Maciej Dybiec; Protein microarrays and spatially resolved photoluminescence in bio-conjugated quantum dots-probes for early cancer detection
345. Karsten Wegner; Production of biocompatible films by controlled gas-phase synthesis and deposition of nanoparticles
346. Sang Im Park; Synthesis of magnetic nanoparticles by thermal decomposition and biocompatibility
Gene Delivery
347. Tomohiro Asai, Gene silencing of mutant K-ras mediated by polycation liposome
348. Ravil A. Sitdikov, Amperometric immunosensor based on highly dipsersed graphite microparticles for influenza virus detection

Controlled Release

349. Divey Saini; Characterization of REP 2006 antiviral drug and drug delivery system for small animal models
350. Janet R. Wendorf; A practical approach to the use of nanoparticles for vaccine delivery
351. Hulda Shaidi Swai; Evaluation of nanoencapsulation performed by spray drying technique for the delivery of Tuberculosis drugs (ATD)
352. Edith C. Rojas; Double carrier systems as novel drug delivery vehicles
353. Sheng Qi; Investigation into using spray chilled Gelucire 50/13 microspheres as carriers for poorly soluble drugs
354. Sara Ponce; Long-term study of EPO-secreting myoblasts entrapped in microcapsules elaborated with five different commercial alginates
355. Jubo Liu; In vivo fate of the micelle forming block copolymer poly(ethylene glycol-block-caprolactone) in mice following intravenous administration
356. Yongwoo Lee; Trehalose bearing polymeric particles: Sorption induced hydrolytic degradation of pesticides and chemical agents
357. Bum Gil Kim; Biodegradable nanoparticles for vaccine delivery systems
358. Jae-Eun Jung; Effective stabilization of bioactive ingredients for long-terrm storage using W/O/W encapsulation and buffering layer
359. E Sócrates. T. Egito; Development of a new multiparticulate system for colon controlled drug delivery
360. E Sócrates. T. Egito; Sodium diclofenac incorporation into xylan microcapsules for colonic drug delivery
361. Masakazu Furuta; Drug release from nanoparticles made of radiation-crosslinked elastin model polypeptides
361b. T.G. Van Thienen; On the synthesis and characterization of biodegradable dextran nanogels with tunable degradation properties

...Somes

362. Per Wessman; Melittin-lipid interactions: A comparison between liposomes and polymer-stabilized nanodiscs
363. Guifang Zhang; Nimodipine-nanoliposomes: Preparation, characterization and pharmacokinetics in rat
364. Maria R. Toler; Determining the dispersion behavior of formulated Bulk drug using light diffraction analysis
365. Jasna Urbanija; Giant phospholipid vesicles as a possible system for studying interactions of membranes with antibodies



Registration


On-Site Registration US$1175
Accompanying Person US$350

Registration Form

Only On-Site Registration Available

Hotel Information

More Hotel Information
Wyndham Orlando Resort
Sold Out
8001 International Drive
Orlando, Florida
Phone: 1-407-351-2420
Fax: (407) 345-5611

A limited room block is available on site at the Wyndham Orlando Resort at the highly favorable rate of US$103 per night (plus 14% taxes) at single or double occupancy. Situated on famed Internationa Drive, this 42 acre site provides urban walking access to diverse international cuisine, shopping, and world famous attractions, while also providing quiet and tropical isolation from the tourist hustle and bustle.

Registration Form

Only On-Site Registration Available

More Hotel Information
Sold Out

Workshops

A series of one day short courses will be presented on Friday and Saturday preceding the start of the conference. A small number of rooms at the Wyndham Orlando Resort at the conference rate of $103 (plus 14% taxes) are available for the evenings of 11 and 12 May.

Friday, May 12th
Small Particle Formation
Introduction to Comminution Size Reduction Technology

Saturday, May 13th
Polymer Nanotechnology - from Synthesis to Application
Particle Characterization
Precision Control of Crystallization Processes

Workshop Registration Form


Photos from the Conference

Professor Frank Szoka, Plenary Lecturer, and Session Chair Professor Diane Burgess Professor Vladimir Torchilin
Dr. Wei Lu (Fudan), Professor (Shirley) Xiao Yu Wu (Toronto), Professor Dan Luo (Cornell), and Professor Tuiji Dai (Tianjin) General Chair John Texter
Dr. Sarah Hook (Otago) Professor Venisetty Raj Kumar (Vaagdevi)
Mike Brown (CPS Instruments) John Caola (FEI) and Andree Kraker (FEI)
Dr. Tejas Desai (Vasogen) and Dr. Natasha Starostina (Pacific Nanotechnology) Dr. Roberta Braynor (Paris 7) and Dr. Anna Maria Carmona-Riberio (Sao Paulo)
Professor Rainer Mueller (PharmaSol) Olev Kahre (Solis BioDyne) and Agu Artma (Solis BioDyne)
Dr. Nakano (NOF) David Mines (Inotech) and X (?)
Professor Diane Burgess (U Conn) Raquel Sousa (IBET, Oerias) and Dr. Robert Tshikhudo (Mintek)
Poster Session Poster Session
Raquel Sousa (IBET, Oerias), Heike Bunjes (Jena) and Meike Harms (Braunschweig) Ijeoma Uchegbu (Strathclyde)
Shlomo Margel (Bar Ilan) Natasha Rapoport (Utah) and Alex Smirnov (North Carolina State) Martine Edsman, Katarina Edsman, Per Wessman, and Nelly Fransé (all from Uppsala)
Hui Chen (Central Florida) and Sudip Nath (Central Florida) Janos Szebeni (Semmelweis)
Jay Schild (Microtrac) and Raquel Sousa (IBET, Oerias) Dean Abadzic (LUM)
X (?) Anna Galperin (Bar Ilan) and Rina Ben Shabat (Bar Ilan)
Dr. Ingo Leubner (Crystallizatoin Consulting), Tridib Bhowmick (IIT, Bombay) and Dr. Hemant Joshi (Spectrum Pharmaceuticals) Professor Venisetty Kumar (Vaagdevi) and Professor Uday Kompella (Nebraska Medical Center)
Melanie Martin (Particles Conference) (right) Kevin Heitfeld (U Cincinnati)



Particles 2006 HomeParticles 2006 Home ProgramProgram Registration InfoRegistration Information Go to Registration Form!
Go to Abstracts PageAbstract Submission Hotel InfoHotel Accomodations Go to ExhibitngExhibiting Workshop InfoWorkshops Go to DirectionsDirections
© 2004-2006 Particles Conference
tel 1-585-288-5913; fax 1-585-482-7795
info@nanoparticles.org